SN-38 has also been proven to enhance anti-tumor immunity by increasing interferon-gamma expression by natural killer (NK) cells and promoting NK and T-cell infiltration in mouse tumor models of head and neck squamous cell carcinoma [54]. This evidence concerns the gene IFNG and head and neck squamous cell carcinoma.